NextFin

ARKK ETF Sells TSLA for $21.6M, Buys CRSP for $4.1M on March 28

Summarized by NextFin AI
  • ARKK ETF experienced a net value change of –$111,919,058.37 on 2026-03-28, indicating a significant shift in portfolio strategy.
  • The largest sell was TSLA (Tesla Inc), with a decrease of $21,622,646.38, suggesting possible profit-taking.
  • The most significant buy was CRSP (CRISPR Therapeutics AG), with an increase of $4,145,780.67, reflecting confidence in the biotech sector.
  • Overall, ARK Invest is adjusting its holdings to maintain growth potential while managing risks in innovative sectors.

ARKK Daily Position Change Report (2026-03-28)

Overview:

ARKK ETF experienced a net value change of –$111,919,058.37 on 2026-03-28 compared to 2026-03-27. The most significant buy was CRSP (CRISPR Therapeutics AG) with an estimated trade value increase of $4,145,780.67. The largest sell was TSLA (Tesla Inc) with a decrease in estimated trade value of $21,622,646.38.

Daily Position Changes Summary:

Ticker Company Name Direction Estimated Trade Value ($) % of Portfolio Change
TSLA Tesla Inc Sell $21,622,646.38 -0.0063%
ROKU Roku Inc-A Sell $21,190,409.61 -0.2207%
AMD Advanced Micro Devices Inc Sell $19,114,399.77 -0.1770%
CRCL None Sell $15,028,261.59 -0.0915%
COIN Coinbase Global Inc-A Sell $10,966,773.94 -0.0337%
PLTR None Sell $10,219,867.40 -0.0474%
HOOD Robinhood Markets Inc-A Sell $7,459,702.71 0.0227%
SHOP Shopify Inc-A Sell $6,607,943.22 0.0482%
CRSP CRISPR Therapeutics AG Buy $4,145,780.67 0.2776%
TEM Tempus AI Inc-A Sell $3,854,834.42 0.1009%

Analysis and Interpretation:

The ARKK ETF's trading activity on 2026-03-28 indicates a strategic repositioning in several key holdings. Increases in weights and values of stocks like CRISPR Therapeutics AG (CRSP) and Tempus AI Inc-A (TEM) suggest confidence in biotech and AI sectors. Conversely, reductions in Tesla (TSLA) and Roku (ROKU) holdings could reflect profit-taking or risk management. Overall, ARK Invest appears to be adjusting exposure to maintain innovation-driven growth potential while managing portfolio risk.


Weekly Summary (Week Ending 2026-03-27)

For the week ending 2026-03-27, ARKK's holdings reflected a focus on maintaining high-conviction positions in innovative sectors, with notable adjustments in key technology and biotech stocks. The data indicates an ongoing strategy to capitalize on growth opportunities while managing risk through selective selling.

Key Weekly Moves:

  • Top Buys:
    • CRSP (CRISPR Therapeutics AG): Increased position reflecting confidence in biotech.
  • Top Sells:
    • TSLA (Tesla Inc): Significant reduction, possibly indicating profit-taking.
    • ROKU (Roku Inc-A): Another notable sell, reflecting a cautious approach towards media and streaming sectors.

This week’s trading activity underscores ARK Invest's commitment to innovation while navigating market volatility.

Explore more exclusive insights at nextfin.ai.

Insights

What are the key principles behind ARK Invest's trading strategy?

How did the ARKK ETF's position changes reflect market trends on 2026-03-28?

What recent shifts have occurred in the ARKK ETF's top holdings?

What impact did Tesla's sell-off have on the ARKK ETF portfolio?

What are the latest updates regarding ARK Invest's approach to biotech stocks?

Which companies are emerging as significant players in the ARKK ETF's portfolio?

How does ARK Invest adjust its holdings to mitigate risk in volatile markets?

What long-term trends are influencing ARK Invest's investment decisions?

What challenges does ARK Invest face in maintaining innovation-driven growth?

How does ARKK ETF's performance compare to other innovation-focused ETFs?

What were the main reasons behind the sell-off of Roku and Tesla stocks?

What trends in AI and biotech sectors are reflected in ARKK's recent buys?

How might changes in user sentiment affect future ARK Invest strategies?

What are the potential risks associated with ARK Invest's focus on high-conviction stocks?

In what ways do recent market conditions shape ARK Invest's portfolio adjustments?

How do ARKK ETF's position changes illustrate the firm's commitment to innovation?

What controversies surround ARK Invest's investment approach and strategies?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App